BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

 Source:  BioStem Technologies, Inc. 3/30/2026

The Company continues its progression towards a Nasdaq uplisting

BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its audited consolidated financial statements as of and for the fiscal years ended December 31, 2024 and 2025. The financial statements are available for review in their entirety on the OTC Markets website here. With the publication of the audited consolidated financial statements, BioStem has taken another significant step toward a Nasdaq uplisting.

“We are pleased to have published our audited financial statements for 2024 and 2025, which marks an important milestone for the Company. Along with the appointment of a new CFO, auditor and audit committee chair, this achievement highlights the significant effort we have made to establish robust financial reporting processes and positions the Company to advance our corporate initiatives, including an uplist to Nasdaq,” said Jason Matuszewski, Chairman and CEO of BioStem. “Listing on Nasdaq remains a top priority that would increase visibility, improve stock liquidity, provide a more precise market valuation, and enhance our ability to attract top talent to BioStem.”

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain^®, CryoTek^® and SteriTek^® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox^®, Clarix^®, VENDAJE^® and American Amnion™ product lines.

 

BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

 

Source:  BioStem Technologies, Inc. 3/23/2026

SEC-Qualified Financial Expert and Life Sciences Veteran Brings 29 Years of Accounting Leadership to the Board

BioStem Technologies (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Jodi Ungrodt to its Board of Directors, where she will also serve as Chair of the Audit Committee, effective March 18, 2026.  

Ungrodt brings nearly three decades of financial leadership to the role, having spent her career as a senior partner at Ernst & Young advising life sciences companies on initial and secondary public offerings, business combinations, risk assessment and regulatory compliance. She is qualified to serve as a financial expert under SEC, NYSE, and NASDAQ rules.

“I am excited to welcome Jodi to our board as we undertake this expansion of our business beyond chronic wound care,” said Jason Matuszewski, Chairman and CEO of BioStem Technologies. “Along with the business expansion, we also plan to raise our profile in the public markets in 2026. Jodi’s twenty-nine years of life sciences accounting experience at Ernst & Young, along with her track record advising more than thirty IPOs and deep regulatory and government expertise, will make a terrific addition to our board governance during this pivotal time.”

BioStem is an emerging leader in placental and umbilical cord–derived tissue products used by clinicians across a variety of medical specialties. Their proprietary allograft portfolio is derived from donated birth tissue and proprietary processes are designed to optimally preserve the tissue’s natural properties. The company continues to conduct leading-edge research to expand the scientific understanding of placental-derived tissue products and to bring new products to market.

As Audit Committee Chair, Ungrodt will oversee the company’s financial reporting, internal controls and risk management practices. Her prior experience includes serving as Chair of the Audit Committee for Feeding San Diego, where she provided accounting, budgeting and risk assessment guidance for over a decade. She is also an Advisory Board Member for Life Science Cares. During her tenure at EY, Ungrodt served more than 70 companies across the Life Sciences sector.

“I am excited to join BioStem’s board at this pivotal time in the company’s growth,” said Ungrodt. “BioStem stands out as one of the most innovative companies in the MedTech sector, driven by strong momentum in the chronic wound market and its recent expansion into acute applications of its industry-leading technologies. These technologies have tremendous potential to improve outcomes in patients, and I’m honored to take on this important role as the company continues to scale and innovate in this space.”

Ungrodt holds a BS in Accounting from San Diego State University and is a Certified Public Accountant and member of the American Institute of Public Accountants and the California Society of CPAs.

Ungrodt replaces former board member Brandon Poe, who accepted the role of BioStem’s chief financial officer in August 2025. Poe brings more than 25 years of finance leadership experience across the healthcare and life sciences sectors. He served on BioStem’s Board of Directors for three years before joining the organization.

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain®, CryoTek® and SteriTek® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox®, Clarix®, VENDAJE® and American Amnion™ product lines.

 

BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

 

Source:  BioStem Technologies, Inc. 2/3/2026

BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today underscored the significance of recent remarks from U.S. Food and Drug Administration (FDA) leadership signaling openness to expanded use of Bayesian statistical methodologies in clinical trial design and analysis.

FDA Commissioner, Dr. Martin Makary recently described the agency’s evolving stance on Bayesian approaches as a “leap forward” for clinical science, noting their potential to improve trial design, dose optimization, pediatric extrapolation, and integration of early-phase data into later-stage studies — a shift aligned with emerging regulatory guidance on Bayesian methods from the agency.

“This is an important and very positive signal from FDA leadership validating the advanced statistical analysis model used in our recently published peer reviewed randomized controlled trial that demonstrates superior outcomes with BioRetain^® - processed allografts in diabetic foot ulcers,” said Jason Matuszewski, CEO and Chairman of BioStem Technologies. “We believe incorporating these metrics into clinical studies enables more efficient discovery; and in terms of our study, helps clinicians better understand the real-world complex wound healing performance of our products.”

In BioStem’s published DFU analysis, Bayesian regression and hurdle modeling were used to move beyond traditional binary endpoints, enabling the company to quantify probability of wound closure, magnitude of response, and treatment effect across heterogeneous patient populations. Similar statistics are expected to be included in the analysis of the Company’s ongoing VLU and DFU studies to enhance the understanding of the clinical benefits of the BioRetain technology.

That recently published study demonstrated that BioRetain-processed allografts achieved superior clinical outcomes in the treatment of patients with DFUs. Importantly, utilizing complete closure instead of initial incidence of closure, the BR-AC arm was almost twice as likely to achieve lasting wound closure than patients treated with standard of care alone. This trial was conducted with a degree of rigor not typically seen in the published literature. The patient selection criteria ensured that only those patients with the hardest-to-heal wounds were enrolled, and the definition of closure followed the 2006 FDA guidance for cutaneous ulcers, the most rigorous standards established.

“These approaches allow us to generate the kind of clinically meaningful insights that physicians, health systems, and policymakers actually need,” Matuszewski added. “Bayesian methodologies are particularly powerful in regenerative medicine and wound care, where datasets are often smaller, variability is high, and real-world evidence matters.”

Echoing this sentiment, Zwelithini Tunyiswa, CEO of Open Wound Research, noted, “FDA Commissioner Makary’s endorsement of Bayesian methods is a welcome recognition of the value these approaches bring to data analysis, synthesis, and planning. Bayesian methods ​allow for innovative designs, and more efficient use of time and resources through the principled incorporation of prior information and sequential learning. Moreover, their reporting of posterior probabilities oftentimes aligns better with wound-care stakeholders where decision-making under uncertainty is key.”

Bayesian statistical frameworks enable the responsible incorporation of prior knowledge alongside new data, supporting probabilistic interpretation and more informed clinical decision-making without compromising scientific rigor. BioStem believes these methods are well suited to biologic technologies and complex wound environments, where patient response can vary widely.

“Seeing the FDA openly embrace these tools is a strong step toward modernizing how evidence is evaluated and how innovation can move efficiently and safely to patients,” Matuszewski said.

BioStem remains committed to advancing evidence-based innovation in wound care through rigorous clinical research and real-world data analysis, supported by its proprietary BioRetain^® process and CryoTek^® cryopreservation technology, both designed to optimize preservation of the natural structural and biological integrity of amniotic tissue.

About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain^® processing method. BioRetain^® has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). Our portfolio of quality brands includes VENDAJE^®, VENDAJE AC^®, American Amnion™, American Amnion AC™, and Neox^® and Clarix^® product lines.

 

Brazil Potash Formalizes Cooperation Agreement With Mura Indigenous Council for Sustainable Territorial Development in Autazes

 

Source:  Brazil Potash Corp 3/23/2026

 

Agreement establishes a framework for social development, cultural appreciation, income generation and institutional strengthening for the Mura Indigenous communities of Autazes

Structured governance and continuous dialogue mechanisms to monitor implementation across all 37 Mura villages

Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company advancing the Autazes potash project in Amazonas State, Brazil (the “Autazes Project” or “Project”), today announced that Potassium do Brasil, its Brazilian operating subsidiary, has formalized a Term of Commitment and Cooperation with the Mura Indigenous Council (Conselho Indígena Mura — “CIM”), establishing a framework for joint action aimed at sustainable territorial development and the improvement of living conditions in indigenous communities in the municipality of Autazes, in Amazonas.

The signing was attended by representatives of Potassium do Brasil, including Project Director Raphael Bloise and the technical team, as well as CIM leaders including General Coordinator Kleber Mura, Deputy Coordinator Adnelson Mura, and Secretary General Matilde Mura, along with legal counsel for the Council.

Raphael Bloise, Project Director of Potassium do Brasil, commented:

“This agreement reinforces our commitment to building, in a responsible and transparent way, a long-term relationship with the communities in the territory. Our goal is to contribute to a development that generates shared value, respecting local culture, rights and priorities.”

The General Coordinator of the CIM, Kleber Mura, added:

“This agreement ensures that our voice continues to be heard and that the benefits reach our communities directly. It is a decisive step for the Good Living of our 37 villages.”

The agreement is part of the broader suite of initiatives associated with the Autazes Project, a strategically important undertaking for Brazilian food security that will contribute to domestic fertilizer production and reduce the country’s dependence on potash imports.

Strengthening the Bem Viver Mura Program

The Cooperation Agreement provides the foundation for strengthening the Bem Viver Mura Program, an initiative structured to support action across four pillars: social development, cultural appreciation, income generation, and institutional strengthening. The planned actions are designed to improve quality of life within the communities involved, with full respect for their socio-cultural specifics, ways of life, and the territorial dynamics of the region.

Commitments and Principles of Action

The agreement is grounded in principles of good faith, transparency, respect for indigenous rights, and continuous dialogue, and is aligned with the guidelines of Convention No. 169 of the International Labour Organization (“ILO”) and international best practices for engagement with indigenous peoples. The consultation and engagement process with communities continues to evolve with a focus on active listening, collaborative solutions, and respect for the full diversity of perspectives across the territory.

Governance and Monitoring

The Cooperation Agreement establishes monitoring mechanisms and structured dialogue, including regular interaction between the parties to track the implementation of actions and promote adjustments over time. The governance framework is designed to ensure transparency, predictability, and ongoing participation throughout the Project’s development cycle.

BOOT Power Supply Arrangements

As previously disclosed, the Company entered into a non-binding memorandum of understanding (the “MOU”) with Fictor Energia S.A. (“Fictor”) for a build-own-operate-transfer (“BOOT”) power supply arrangement for the Autazes Project, contemplating the construction and operation of an approximately 300 MW power generation facility at an estimated construction cost of approximately US$200 million. The MOU has lapsed in accordance with its terms and has not been renewed or extended. The Company is actively engaged in discussions with other power supply providers regarding similar BOOT or other power supply arrangements for the Autazes Project. There can be no assurance that the Company will be able to enter into a definitive power supply agreement on acceptable terms, or at all.

Going Concern

Brazil Potash filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on March 23, 2026. As disclosed in the Form 20-F, the audited consolidated financial statements for the fiscal year ended December 31, 2025 contained an audit opinion from the Company’s independent registered public accounting firm that included an emphasis of matter paragraph relating to substantial doubt about the Company’s ability to continue as a going concern. This announcement is made pursuant to Section 610(b) of the NYSE American Company Guide, which requires a separate public announcement of the receipt of an audit opinion containing a going concern emphasis. This announcement does not represent any change or amendment to the Company’s audited consolidated financial statements or its annual report on Form 20-F for the fiscal year ended December 31, 2025.

About the Mura Indigenous Council (CIM)

The Mura Indigenous Council is the representative entity of the Mura people in Autazes, acting in the defence of collective rights, cultural appreciation and institutional strengthening of their communities.

About Brazil Potash

Brazil Potash (NYSE-American: GRO) (www.brazilpotash.com) is developing the Autazes Project to supply sustainable fertilizers to one of the world’s largest agricultural exporters. Brazil is critical for global food security as the country has amongst the highest amounts of fresh water, arable land, and an ideal climate for year-round crop growth, but it is vulnerable as it imported over 95% of its potash fertilizer in 2024, despite having what is anticipated to be one of the world’s largest undeveloped potash basins in its own backyard. The potash produced will be transported primarily using low-cost river barges on an inland river system in partnership with Amaggi (www.amaggi.com.br), one of Brazil’s largest farmers and logistical operators of agricultural products. With an initial planned annual potash production of up to 2.4 million tons per year, Brazil Potash’s management believes it could potentially supply approximately 20% of the current potash demand in Brazil. Management anticipates 100% of Brazil Potash’s production will be sold domestically to reduce Brazil’s reliance on potash imports while concurrently mitigating approximately 1.4 million tons per year of GHG emissions.

 

Brazil Potash Reports Significant Site Progress Including Federal Water Rights Approval, Indigenous Community Partnership Advancement, and Construction Financing Initiatives

 

Source:  Brazil Potash Corp. 2/11/2026

Brazil’s National Water and Sanitation Agency (ANA) grants 10-year water extraction rights from the Rio Madeira, eliminating need for sixteen deep groundwater wells and reducing construction costs

WSP Global commences demographic and needs analysis across 36 Mura indigenous communities toward development of a Wellbeing Plan

Third-party proposals received for Build, Own, Operate and Transfer of port, steam plant, and 20MW construction power infrastructure

Construction financing discussions advancing with Global Development Finance Institutes, Export Credit Agencies, and major equipment suppliers

Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company with a critical mineral potash agriculture project, the Autazes Potash Project (the “Project”), today announced a series of significant progress updates at the Project, including the receipt of federal water extraction rights, the commencement of indigenous community partnership work, and the advancement of construction financing initiatives. The Project has obtained 21 Installation Licenses, permitting construction of the mine shafts, processing plant and upgrades to eight miles of road connecting the plant to the port and river barge port.

“The progress we are announcing today demonstrates the continued forward momentum at Autazes across multiple critical workstreams,” said Matt Simpson, Chief Executive Officer of Brazil Potash. “Securing federal water rights from ANA is both a regulatory milestone and an engineering improvement that simplifies our design and reduces costs. WSP Global’s engagement with the 36 Mura communities reflects our deep commitment to developing this project in genuine partnership with indigenous peoples – ensuring that the communities closest to the project share meaningfully in its benefits. On the financing side, the Build, Own, Operation & Transfer (BOOT) proposals for key infrastructure and the advancing discussions with DFIs, ECAs, and equipment suppliers demonstrate the breadth of interest from credible parties in supporting the construction of this strategically important project. Every milestone we achieve brings Brazil one step closer to breaking its dependence on imported potash and securing its future as the world's agricultural leader.”

Federal Water Extraction Rights Granted

Brazil Potash has obtained approval from ANA, Brazil’s National Water and Sanitation Agency (Agência Nacional de Águas e Saneamento Básico - ANA), to extract water from the Rio Madeira for use in the processing of potash ore at the Project. The grant of water rights, dated January 30, 2026, authorizes the Company to extract up to 2,400 cubic meters per hour for 12 hours per day, equivalent to an annual volume of approximately 10.5 million cubic meters, for a 10-year term.

This approval represents a meaningful design optimization for the Project. As originally planned, the Company expected to sink approximately sixteen groundwater wells to a depth of roughly 250 meters to extract groundwater for ore processing. The ANA approval to instead utilize surface water from the Rio Madeira river is anticipated to result in a reduction in construction costs by eliminating the need for these deep wells. According to the Amazonas State Environmental Protection Agency IPAAM, this solution aligns with regulatory guidelines that prioritize surface water use when environmentally appropriate and economically viable. 

The Company’s water management strategy includes recycling the vast majority of water used in processing, collecting natural surface water runoff, and operating a water purification plant as an integral part of the project design with fresh makeup water used to meet water quality and flow requirements.

Indigenous Community Partnership Advancement

WSP Global, one of the world’s leading professional services firms, has initiated technical support activities with the Mura Indigenous communities previously consulted as part of the process to obtain the construction Installation Licenses, in line with internationally recognized engagement practices. 

The initiative seeks to support the Mura people in the systematization and refinement of their own development priorities, contributing to the strengthening of the Mura Wellbeing Plan and to the identification of opportunities for social inclusion, capacity building, and community wellbeing. The activities are designed to inform future dialogue and collaborative actions, respecting the autonomy, cultural values, and self-determined vision of the Mura communities.

Third-Party Infrastructure Financing Proposals

The Company has recently received proposals for third-party funding to Build, Own, Operate and Transfer (“BOOT”) construction of several key infrastructure components, including the river barge port facility, the steam plant, and a 20MW construction power system that is designed to convert to backup power during the operations phase. These proposals are currently being analyzed and, if advanced, have the potential to reduce the Company’s direct capital requirements by shifting certain infrastructure costs to third-party operators.

Construction Financing Discussions Progressing

Discussions with various groups including Global Development Finance Institutes (“DFIs”), Export Credit Agencies (“ECAs”), and major equipment suppliers to fund construction of the Autazes Project are progressing well. The Company continues to engage with multiple parties across these categories as it advances toward securing the financing necessary to commence full-scale construction.

About Brazil Potash

Brazil Potash (NYSE-American: GRO) (www.brazilpotash.com) is developing the Autazes Project to supply sustainable fertilizers to one of the world’s largest agricultural exporters. Brazil is critical for global food security as the country has amongst the highest amounts of fresh water, arable land, and an ideal climate for year-round crop growth, but it is vulnerable as it imported over 95% of its potash fertilizer in 2024, despite having what is anticipated to be one of the world’s largest undeveloped potash basins in its own backyard. The potash produced will be transported primarily using low-cost river barges on an inland river system in partnership with Amaggi (www.amaggi.com.br), one of Brazil’s largest farmers and logistical operators of agricultural products. With an initial planned annual potash production of up to 2.4 million tons per year, Brazil Potash’s management believes it could potentially supply approximately 20% of the current potash demand in Brazil. Management anticipates 100% of Brazil Potash’s production will be sold domestically to reduce Brazil’s reliance on potash imports while concurrently mitigating approximately 1.4 million tons per year of GHG emissions

 

Comstock Metals Receives DTSC Recycling Approval for California Facility; Strengthening National Recycling Network and Major Market Reach

 

Source:  Comstock, Inc. 2/23/2026

Comstock Inc. (NYSE: LODE) (“Comstock” or the “Company”) and its subsidiary, Comstock Metals LLC (“Comstock Metals”), a leader in the responsible recycling of end-of-life solar panels and the only certified, zero-landfill solar recycling solution in North America, today announced that following the opening of its facility in Kings County, CA, it has received approval from California’s Department of Toxic Substances Control (“DTSC”) and has been placed on a very select list of companies authorized as universal waste recyclers that can treat photovoltaic (“PV”) modules.  The recently opened facility in combination with this new “certification” now avails California companies with a true “California solution” for recycling end of life PV solar panels that is authorized by the DTSC and supported by several strategic customers.

This new California facility, and recent certification, marks a regional expansion and optimization of Comstock Metals’ southwestern recycling network, reinforcing the company’s commitment to serving high-demand California-based renewable energy customers. Strategically located to optimize logistics and support customers across California—the single largest end-of-life U.S. solar panel market by far—the site will operate as a centralized hub for the collection, preparation, storage, and aggregation of decommissioned PV solar panels.

As increasing numbers of solar panels reach the end of their useful life across California, Arizona and Nevada, demand is rapidly growing for compliant, environmentally responsible recycling solutions. The California facility is purpose-built to meet this need, providing major utilities, developers, engineering and construction firms (EPCs), installers, decommissioning contractors, and asset owners with a dependable, locally based option for managing these environmental liabilities. Through advanced recovery processes, valuable materials—including aluminum, silver, copper, gallium, and other metals—can eventually be extracted and returned to the supply chain for reuse.

“Opening a facility in California positions us to better serve the region’s increasing demand for end-of-life solar panel disposal while delivering a streamlined, cost-effective logistics solution for our customers,” said Dr. Fortunato Villamagna, President of Comstock Metals. “Our mission is to close the loop on solar energy by ensuring the environmental liabilities associated with these retired panels are safely, cleanly and completed eliminated so they do not find their way into landfills and ultimately, our natural water and broader eco-systems.”

By delivering timely, efficient, and fully compliant decommissioning, transportation, and recycling services, Comstock’s zero-landfill solution minimizes waste, preserves natural resources, and advances the long-term sustainability of the solar industry. The Company is also completing permit applications and preparing submission plans for a second, integrated, industry-scale facility in Nevada, with final site selection expected later this month.

“As the number of end-of-life solar panels nationwide rises into the tens and eventually hundreds of millions, our ability to scale responsibly and efficiently ensures meaningful sustainability outcomes—and confidence—for our customers and partners,” said Corrado De Gasperis, Executive Chairman and CEO of Comstock. “Our team is establishing a new benchmark for solar panel recycling through a growing, fully integrated national network.”

About Comstock Inc.

Comstock Inc. (NYSE: LODE) innovates and commercializes technologies, systems and supply chains that enable, support and sustain clean energy systems by efficiently, effectively, and expediently extracting and converting under-utilized natural resources into reusable metals, like silver, aluminum, gold, and other critical minerals, primarily from end-of-life photovoltaics.

 

Comstock Metals Awarded Tax Abatement From the Nevada Governor’s Office of Economic Development

 

Source:  Comstock, Inc. 2/9/2026

Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) and its subsidiary, Comstock Metals LLC (“Comstock Metals”), a leader in the responsible recycling of end-of-life solar panels and the only certified, zero-landfill solar recycling solution in North America, today announced that it has received tax abatements from the Nevada Governor’s Office of Economic Development (“GOED”).

GOED awarded approximately $900,000 in tax abatements that will apply to Comstock Metals’ first-of-its-kind zero-landfill, solar panel recycling and critical metal production facility that is scheduled to commence production in the second quarter of 2026, with the initial recycling capacity of approximately 3.3 million panels or approximately 100,000 tons of recycled material per year. Comstock Metals recently received all its remaining permits from the State of Nevada for its breakthrough solar panel recycling processes located in Silver Springs, in northern Nevada and is currently operating in its pilot facility.

In connection with the abatement program, Comstock Metals will create at least 43 diverse, well-paying jobs and make over $12 million in capital investments within the first year of operation. Over the 10-year abatement period, it is estimated that this operation will result in more than $7 million in net new Nevada tax revenues.

“We are thrilled with GOED’s support and recognition of the value that Comstock Metals brings in terms of economic, environmental, and community benefits, as this remarkable, first of its kind clean technology business is anchored in Nevada. We are positioned to serve the entire southwest region of the United States and keep these hazardous wastes out our landfills and our ecosystem,” said Corrado De Gasperis, Comstock’s Executive Chairman and Chief Executive Officer. “Securing and recycling these panels enables an even bigger second phase where we plan to cleanly refine and produce these metals. This includes silver, copper, silicon, and many other critical metals that establishes us as leaders in the domestic electrification metals supply chain.”

About Comstock Inc.

Comstock Inc. (NYSE: LODE) innovates and commercializes technologies, systems and supply chains that enable, support and sustain clean energy systems by efficiently, effectively, and expediently extracting and converting under-utilized natural resources into reusable metals, like silver, aluminum, gold, and other critical minerals, primarily from end-of-life photovoltaics.